Sort
64,565 grants matching “drug discovery”
Optimization of methionyl-tRNA synthetase inhibitors for human African trypanosomiasis
$696,541Erkang Fan · University Of Washington · R01 · FY2019 · AI
A phenotypic screen for osteoarthritic pain therapeutics using all-optical electrophysiology.
$696,518Hongkang Zhang · Quiver Bioscience Inc. · R44 · FY2021 · AR
A Bioengineering Approach to Develop a Laminar 3D Cerebellar Neuronal Circuit for Modeling Human Cerebellum
$696,516Kathleen Joyce Millen · Seattle Children'S Hospital · R01 · FY2024 · NS
Neonatal Opioid Exposure and Withdrawal: Molecular and Behavioral Consequences
$696,506Julie A Blendy · University Of Pennsylvania · R01 · FY2022 · DA
Neonatal Opioid Exposure and Withdrawal: Molecular and Behavioral Consequences
$696,506Julie A Blendy · University Of Pennsylvania · R01 · FY2023 · DA
Neonatal Opioid Exposure and Withdrawal: Molecular and Behavioral Consequences
$696,506Julie A Blendy · University Of Pennsylvania · R01 · FY2024 · DA
Discovery of novel benzimidazole resistance mechanisms
$696,385Erik Christian Andersen · Northwestern University · R01 · FY2021 · AI
Network Resource
$696,361Sook Wah Yee · University Of California, San Francisco · U19 · FY2013 · GM
The LINCS DCIC Engagement Plan with the CFDE
$696,280Avi Ma'ayan · Icahn School Of Medicine At Mount Sinai · OT2 · FY2022 · OD
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
$696,239Li Zhou · Brigham And Women'S Hospital · R01 · FY2020 · AI
Novel Probes of the Kappa Opioid Receptor: Chemistry, Pharmacology, and Biology
$696,122Laura M Bohn · Scripps Florida · R01 · FY2015 · DA
Fox COBRE Phase II Admin Core
$696,115Joseph M Fox · University Of Delaware · P20 · FY2022 · GM
Inhibitors of protein-protein interactions
$696,075Nadya Tarasova · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Decoding Astrocyte Signaling in Neural Circuitry with Novel Computational Modeling and Analytical Tools
$695,922Guoqiang Yu · Virginia Polytechnic Inst And St Univ · R01 · FY2022 · MH
Development of Kv3.1 potentiators for correcting fast-spiking-interneuron hypofunction in schizophrenia and autism spectrum disorder
$695,775Jerod S Denton · Vanderbilt University Medical Center · R01 · FY2023 · MH
Implementing A QSP Platform to Predict and Test Drugs for Metabolic Associated Fatty Liver Disease Genetic Variants in an iPSC-cell Based Human Biomimetic Liver Microphysiology System
$695,586Mark T. Miedel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Optimizing HIV Treatment Monitoring under Resource Constraints
$695,576Joseph W Hogan · Brown University · R01 · FY2017 · AI
Single-cell resolution analysis of chromatin accessibility and gene expression changes in a model of drug addiction
$695,538Francesca Telese · University Of California, San Diego · U01 · FY2021 · DA
Preclinical validation of ABHD5 as a target for treatment of obesity.
$695,461James G Granneman · Wayne State University · R01 · FY2016 · DK
7/7 Psychiatric Genomics Consortium: Finding actionable variation
$695,417Arpana Agrawal · Washington University · U01 · FY2016 · MH
Advancing algorithms for image-based profiling
$695,400Anne E. Carpenter · Broad Institute, Inc. · R35 · FY2020 · GM
Advancing algorithms for image-based profiling
$695,400Anne E. Carpenter · Broad Institute, Inc. · R35 · FY2019 · GM
Advancing algorithms for image-based profiling
$695,400Anne E. Carpenter · Broad Institute, Inc. · R35 · FY2021 · GM
Advancing algorithms for image-based profiling
$695,400Anne E. Carpenter · Broad Institute, Inc. · R35 · FY2018 · GM
Rational Design of antivrials targeted to HIV-1 capsid
$695,365Asim K Debnath · New York Blood Center · R01 · FY2012 · AI